Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0000950170-23-072763

Chief Financial Officer acquired 134,953 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Burrows Scott L · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-22 Grant or award : show line 1 in the form +134,953 134,953 D
Loading xslF345X05/ownership.xml…